SeaAhead Amritam Protein I, A Series of Assure Labs 2020, LLC — Form D
SeaAhead Amritam Protein I, A Series of Assure Labs 2020, LLC of Salt Lake City, UT, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2021-02-02. The offering totals $261K, of which $261K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-02-02
- Form: D
- Accession: 0001837656-21-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $261K
- Amount sold: $261K
- Minimum investment: $10K
- Investors: 15
- Date of first sale: 2021-01-29
- Security types: fund interests
- SEC file number: 021-388103
Issuer
- Name: SeaAhead Amritam Protein I, A Series of Assure Labs 2020, LLC
- CIK: 0001837656
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6510 S Millrock Drive, Salt Lake City, UT, 84121
- Phone: (801) 419-0677
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Richard Thoms | Executive Officer | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
Other filings by this issuer (1)
More